Want to track the performance of this manager?
Click the button below to sign up to receive monthly performance updates by email.Track Manager
Want more information on investing with this manager?
If you are interested in investing in one of Justin Uyehara's funds. Click the link below to get started.Invest Today
The Duchenne Muscular Dystrophy (DMD) community today has reason to celebrate because the FDA finally granted approval for Sarepta’s (SRPT) eteplirsen. However, it is shameful that the FDA’s Read More...
SEP 19, 2016 | Forbes Article
Novavax (NASDAQ:NVAX) closed at $9.26 on Tuesday. On Wednesday, the stock closed at $7.98, down nearly 14%. On Thursday, it closed at $7.58 down another 5%. Here's what happened. Read More...
MAR 26, 2015 | Forbes Featured
NOV 20, 2014 | Forbes Featured
JUN 19, 2014 | Forbes Featured
You do not have permission to view this fund. Please select the "Overview" tab, or select a fund tab above.